Growth Metrics

Baxter International (BAX) Revenue (2016 - 2024)

Baxter International (BAX) has disclosed Revenue for 16 consecutive years, with $2.8 billion as the latest value for Q4 2024.

  • Quarterly Revenue rose 0.88% to $2.8 billion in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.8 billion through Sep 2025, down 74.06% year-over-year, with the annual reading at $11.2 billion for FY2025, 5.72% up from the prior year.
  • Revenue for Q4 2024 was $2.8 billion at Baxter International, up from $2.7 billion in the prior quarter.
  • The five-year high for Revenue was $3.7 billion in Q4 2022, with the low at $2.4 billion in Q1 2023.
  • Average Revenue over 5 years is $3.0 billion, with a median of $2.8 billion recorded in 2020.
  • The sharpest move saw Revenue skyrocketed 30.22% in 2022, then plummeted 31.39% in 2023.
  • Over 5 years, Revenue stood at $3.2 billion in 2020, then fell by 9.59% to $2.9 billion in 2021, then surged by 30.22% to $3.7 billion in 2022, then dropped by 27.13% to $2.7 billion in 2023, then increased by 0.88% to $2.8 billion in 2024.
  • According to Business Quant data, Revenue over the past three periods came in at $2.8 billion, $2.7 billion, and $2.7 billion for Q4 2024, Q3 2024, and Q2 2024 respectively.